70
Participants
Start Date
August 20, 2019
Primary Completion Date
January 30, 2027
Study Completion Date
March 30, 2027
Break Wave extracorporeal lithotripsy
The Break Wave device will be used to exert a low amplitude burst of ultrasound waves focused at the kidney stone. The primary components of the device include an 85 mm aperture diameter therapy probe driven by a high voltage generator. The therapy probe has a cavity in the middle to accommodate coaxial alignment of an ultrasound imaging probe for treatment guidance.
COMPLETED
University of California San Diego Health, San Diego
COMPLETED
University of California, San Francisco, San Francisco
COMPLETED
University of Washington Medical Center, Seattle
COMPLETED
University of Alberta, Division of Urology, Edmonton
RECRUITING
Vancouver General Hospital Stone Centre, Vancouver
NOT_YET_RECRUITING
St. Michael's Unity Health Toronto, Toronto
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
SonoMotion
INDUSTRY